Institute launch to tackle infectious disease threats

Institute of infectious diseases

‘Critical mass’ of scientists launches Institute to tackle infectious disease threats: Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease. The new Institute of Infection brings together one of the largest critical masses of researchers working across infectious disease, anywhere in the world. Building on the […]

Read More… from Institute launch to tackle infectious disease threats

Merck and Ridgeback’s Antiviral Molnupiravir trial

COVID-19 drugs

News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared […]

Read More… from Merck and Ridgeback’s Antiviral Molnupiravir trial

Cancer Treatment influences vaccine response

vaccine

The type of cancer treatment influences vaccine response: Cancer patients are at increased risk of SARS-CoV-2 infection and severe COVID-19 courses. Coronavirus vaccination is generally recommended for cancer patients, but so far little is known about how well they respond to the vaccine. In a study now published in the high-ranking journal JAMA Oncology (Impact […]

Read More… from Cancer Treatment influences vaccine response

New imaging for targeted cancer therapy

skin cancer treatment

Novel fluorescence imaging assay gives new insight to develop biomimetic nanoparticles for targeted cancer therapy. Cell membrane coated biomimetic nanoparticles (NPs) have been widely studied in nanomedicine because of their unique properties such as immune escaping, long blood circulation, specific molecular recognition and efficient cancer targeting, indicating a great potential in targeted cancer therapy. However, […]

Read More… from New imaging for targeted cancer therapy

Diabetes UK responds to research at EASD

Diabetes UK responds to discussion on huge and growing primary care needs of people with diabetes who have survived COVID-19 at EASD.  Nikki Joule, Policy Manager at Diabetes UK, said: “People with diabetes have been disproportionately affected by the pandemic, with a third of Covid-19 deaths in England occurring in those with diabetes during the […]

Read More… from Diabetes UK responds to research at EASD

Strategic Action for Health in Small Island Developing States

The Hippocratic Post - malaria

WHO is hosting the first global gathering of leaders focusing exclusively on health in Small Island Developing States, or SIDS. The SIDS Summit for Health brings together SIDS heads of states, ministers of health and others to discuss the urgent health challenges and needs they face. It will help amplify SIDS voices, promote collaborative action […]

Read More… from Strategic Action for Health in Small Island Developing States

RSM COVID-19 Series | Episode 88: LGBTQ+ health and care in the pandemic

Recorded on Thursday 16 September 2021, as part of the Royal Society of Medicine’s COVID-19 Series. This episode explored how the pandemic and multiple national lockdowns have impacted the LGBTQ+ community. To explore the range of impacts, and what needs to happen going forward, we welcomed Dr Callum Phillips, LGBTQ+ Lead at The British Student […]

Read More… from RSM COVID-19 Series | Episode 88: LGBTQ+ health and care in the pandemic

Breaks, sprains or dislocations

sprains

Breaks, sprains or dislocations – what you need to know! From skiing, slipping whilst running round the side of a swimming pool, trampolining … or just falling badly, they happen all the time, and they are tricky injuries to avoid.  Whilst breaks and sprains are extremely common, it is difficult to know whether you have broken […]

Read More… from Breaks, sprains or dislocations